Answers are grounded in this paper and cite their sources.
Case report reveals contrast-induced encephalopathy in patients undergoing neurointerventional procedures, highlighting the importance of early recognition and management.
Contrast-induced encephalopathy (CIE) is a rare adverse complication of various diagnostic and therapeutic angiographic procedures following iodinated contrast media administration. Disruption of the blood–brain barrier is the center point of underlying mechanism. It mimics subarachnoid hemorrhage (SAH) on computed tomography (CT) scan. Patient usually present early with wide range of symptoms of neurological deficit; however, late presentations have been documented in literatures. Most of these cases are transient resolving within 48 hours but fatal outcomes have been reported. The purpose of this article was to report three cases who underwent endovascular intervention at our center and developed CIE. All these three patients had untreated hypertension. Iopamidol as contrast agent was used in all these cases. All three patients developed stroke-like symptoms in the postoperative period and radiological investigations revealed a picture of SAH with dual-energy iodinated CT confirming CIE. All patients were managed according to our institutional protocol and made recovery. It is paramount to recognize this potentially devastating complication early after carefully excluding thromboembolic and hemorrhagic causes. Once diagnosed, early initiation of conservative treatment include hydration therapy, anticonvulsants, institute selective use of steroids, and osmotherapy such as mannitol. Adequate preoperative management of hypertension may play an important role in the prevention of CIE. Future use of contrast should include meticulous risk assessment and exhaustive patient and relatives counseling.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: